AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?
Authors: Halimi, JM Forhan, A Balkau, B Novak, M Wilpart, E Tichet, J Marre, M
Citation: Jm. Halimi et al., Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?, J CARD RISK, 8(3), 2001, pp. 139-146
Managing diabetic nephropathy before and during pregnancy
Authors: Stevenin, C Collet, C White, C Marre, M
Citation: C. Stevenin et al., Managing diabetic nephropathy before and during pregnancy, DIABETE MET, 27(4), 2001, pp. S42-S47
Insulin sensitivity, blood pressure and cardiovascular diseases
Authors: Marre, M Collet, C Moisan, C Stevenin, C Larger, E
Citation: M. Marre et al., Insulin sensitivity, blood pressure and cardiovascular diseases, DIABETE MET, 27(2), 2001, pp. 229-232
Interest of Clinitek (R) microalbumin in screening for microalbuminuria: Results of a multicentre study in 302 diabetic patients
Authors: Le Floch, JP Marre, M Rodier, M Passa, P
Citation: Jp. Le Floch et al., Interest of Clinitek (R) microalbumin in screening for microalbuminuria: Results of a multicentre study in 302 diabetic patients, DIABETE MET, 27(1), 2001, pp. 36-39
Prognostic value of angiotensin-1 converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study
Authors: Hadjadj, S Belloum, R Bouhanick, B Gallois, Y Guilloteau, G Chatellier, G Alhenc-Gelas, F Marre, M
Citation: S. Hadjadj et al., Prognostic value of angiotensin-1 converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study, J AM S NEPH, 12(3), 2001, pp. 541-549
Glycaemic control in type I diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study
Authors: Tamas, G Marre, M Astorga, R Dedov, I Jacobsen, J Lindholm, A
Citation: G. Tamas et al., Glycaemic control in type I diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study, DIABET RE C, 54(2), 2001, pp. 105-114
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
Authors: Huang, W Gallois, Y Bouby, N Bruneval, P Heudes, D Belair, MF Krege, JH Meneton, P Marre, M Smithies, O Alhenc-Gelas, F
Citation: W. Huang et al., Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse, P NAS US, 98(23), 2001, pp. 13330-13334
Microalbuminuria and markers of the atherosclerotic process: the DESIR study
Authors: Mennen, LI Balkau, B Royer, B Caradec, A Marre, M Balkau, B Eschwege, E Alhenc-Gelas, F Bechetoille, A Gallois, Y Girault, A Marre, M Brochier, M Chesnier, MC Gasnier, M Le Mauff, JM Caradec, A Arondel, D Novak, M Petrella, A D'Hour, A Lepinay, P Royer, B Verstraete, N Aubourg, P Cogneau, J Rougeron, C Diquero, V Caces, E Cailleau, M Jacquelin, JM Moreau, JG Rakotozafy, F Tichet, J Vol, S
Citation: Li. Mennen et al., Microalbuminuria and markers of the atherosclerotic process: the DESIR study, ATHEROSCLER, 154(1), 2001, pp. 163-169
Study Rationale and Design of ADVANCE: Action in and vascular disease - preterax and diamicron MR evaluation
Authors: Chalmers, J Cooper, M Ferrannini, E Glasziou, P Grobbee, D Hamet, P Harrap, S Liu, L MacMahon, S Mancia, G Marre, M Matthews, D Mogensen, C Neal, B Pan, CY Poulter, N Rodgers, A Williams, B Woodward, M
Citation: J. Chalmers et al., Study Rationale and Design of ADVANCE: Action in and vascular disease - preterax and diamicron MR evaluation, DIABETOLOG, 44(9), 2001, pp. 1118-1120
Hereditary factors in the development of diabetic renal disease
Authors: Marre, M Hadjadj, S Bouhanick, B
Citation: M. Marre et al., Hereditary factors in the development of diabetic renal disease, DIABETE MET, 26, 2000, pp. 30-36
Normal and abnormal day-to-day variability of urinary albumin excretion incontrol and diabetic subjects
Authors: Chau, NP Bouhanick, B Mestivier, D Taki, M Marre, M
Citation: Np. Chau et al., Normal and abnormal day-to-day variability of urinary albumin excretion incontrol and diabetic subjects, DIABETE MET, 26(1), 2000, pp. 36-41
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein
Authors: Hadjadj, S Gallois, Y Simard, G Bouhanick, B Passa, P Grimaldi, A Drouin, P Tichet, J Marre, M
Citation: S. Hadjadj et al., Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein, NEPH DIAL T, 15(12), 2000, pp. 1971-1976
The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and Ramipril (DIABHYCAR) study: Design, organization, and patient recruitment
Authors: Lievre, M Marre, M Chatellier, G Plouin, PF Reglier, JC Richardson, L Bugnard, F Vasmant, D
Citation: M. Lievre et al., The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and Ramipril (DIABHYCAR) study: Design, organization, and patient recruitment, CONTR CL TR, 21(4), 2000, pp. 383-396
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa
Authors: Marre, M Lievre, M Vasmant, D Gallois, Y Hadjadj, S Reglier, JC Chatellier, G Mann, J Viberti, GC Passa, P
Citation: M. Marre et al., Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa, DIABET CARE, 23, 2000, pp. B40-B48
Efficacy of diuretics and beta-blockers in diabetic hypertensive patients - Results from a meta-analysis
Authors: Lievre, M Gueyffier, F Ekbom, T Fagard, R Cutler, J Schron, E Marre, M Boissel, JP
Citation: M. Lievre et al., Efficacy of diuretics and beta-blockers in diabetic hypertensive patients - Results from a meta-analysis, DIABET CARE, 23, 2000, pp. B65-B71
Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type 1 diabetes
Authors: Lacquemant, C Gaucher, C Delorme, C Chatellier, G Gallois, Y Rodier, M Passa, P Balkau, B Mazurier, C Marre, M Froguel, P
Citation: C. Lacquemant et al., Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type 1 diabetes, KIDNEY INT, 57(4), 2000, pp. 1437-1443
Normal and abnormal daily urinary albumin excretion.
Authors: Chau, NP Bouhanick, B Mestivier, D Taki, M Marre, M
Citation: Np. Chau et al., Normal and abnormal daily urinary albumin excretion., ARCH MAL C, 93(8), 2000, pp. 1023-1027
Changes in glycaemic control (but not in body weight control) are positively correlated with changes in coronary risk profile in diabetic patients.
Authors: Hadjadj, S Guilloteau, G Weekers, L Bouhanick, B Fressinaud, P Marre, M
Citation: S. Hadjadj et al., Changes in glycaemic control (but not in body weight control) are positively correlated with changes in coronary risk profile in diabetic patients., ARCH MAL C, 93(8), 2000, pp. 1033-1036
Hypertension and diabetes.
Authors: Bouhanick, B Barbosa, SLS Marre, M
Citation: B. Bouhanick et al., Hypertension and diabetes., ARCH MAL C, 93(11), 2000, pp. 1429-1434
Microalbuminuria in hypertension: Measurement, variations, interpretation and recommendations
Authors: Hornych, A Marre, M Mimran, A Chaignon, M Asmar, R Fauvel, JP
Citation: A. Hornych et al., Microalbuminuria in hypertension: Measurement, variations, interpretation and recommendations, ARCH MAL C, 93(11), 2000, pp. 1304-1308
Contribution of hypertension to vascular risk in diabetic patients.
Authors: Marre, M Bouhanick, B Hadjadj, S Weekers, L
Citation: M. Marre et al., Contribution of hypertension to vascular risk in diabetic patients., DIABETE MET, 25, 1999, pp. 27-31
Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women's healthier cardiovascular risk profile. The DESIR Study
Authors: Bertrais, S Balkau, B Vol, S Forhan, A Calvet, C Marre, M Eschwege, E
Citation: S. Bertrais et al., Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women's healthier cardiovascular risk profile. The DESIR Study, INT J OBES, 23(10), 1999, pp. 1085-1094
Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1diabetes
Authors: Marre, M Bouhanick, B Berrut, G Gallois, Y Le Jeune, JJ Chatellier, G Menard, J Alhenc-Gelas, F
Citation: M. Marre et al., Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1diabetes, HYPERTENSIO, 33(3), 1999, pp. 775-780
Relationship between glomerular hyperfiltration and ACE insertion/deletionpolymorphism in type 1 diabetic children and adolescents
Authors: Bouhanick, B Gallois, Y Hadjadj, S de Casson, FB Limal, JM Marre, M
Citation: B. Bouhanick et al., Relationship between glomerular hyperfiltration and ACE insertion/deletionpolymorphism in type 1 diabetic children and adolescents, DIABET CARE, 22(4), 1999, pp. 618-622
Genetics and the prediction of complications in type 1 diabetes
Authors: Marre, M
Citation: M. Marre, Genetics and the prediction of complications in type 1 diabetes, DIABET CARE, 22, 1999, pp. B53-B58
Risultati: 1-25 | 26-29